It looks like nothing was found at this location. Maybe try one of the links below or a search?
Recent Posts
- Using implementation science to evaluate a population-wide genomic screening program: Findings from the first 20,000 In Our DNA SC participants
- Pharmacogenomic testing in oncology: a health system’s approach to identify oncology provider perspectives
- GUARDD-US Team Surpasses Enrollment Goal
- ADOPT-PGx Team Reaches End-of-Enrollment Milestone
- CCPM’s Biobank unearths disease risk and pinpoints problems with medications
Most Used Categories
- Publication (161)
- PGx (59)
- News (57)
- Events (56)
- Clinical Implementation (22)
- Risk Assessment/FHH (17)
- Uncategorized (15)
- ADOPT News (15)
- GUARDD News (15)
- IGNITE Network (14)
Archives
Try looking in the monthly archives. 🙂
Tags
artificial intelligence
biobank
biomarkers
biomedical science
cancer
cancer screenings
clinical decision support
clinical genetics
COVID-19
data-driven healthcare
disease prevention
diversity
DNA sequencing
events
family history
genetic risk factors
genetics
genetic testing
genetic variants
genomic medicine
genomics
genomic screening
genomic sequencing
genomics research
genotyping
health disparities
health equity
human genetics
human genome research
human genomics
implementation
implementation science
newborn screening
pharmacogenetics
pharmacogenomics
polygenic risk scores
population genomic screening
population health
precision health care
precision medicine
precision public health
public health
public health genomics
rare disease
Rare Diseases